Thermo Fisher Scientific reported a 3 percent year-over-year revenue growth to $10.86 billion in Q2, beating analyst expectations. The company raised its full-year revenue guidance to between $43.6 and $44.2 billion and increased adjusted EPS outlook, citing active cost management including $300 million in additional reductions. The updated guidance also factors in easing tariff tensions between the US and China. Following the earnings beat, Thermo Fisher’s stock surged roughly 11 percent. CFO Stephen Williamson announced his planned retirement in 2026, with Jim Meyer named as successor.